As well as the potential for peripheral KP dysregulation driving depression, additional evidence suggests that the aging brain has increased BBB permeability with peripheral immunopeptides/cytokines being more likely to enter the CNS and upregulate IDO-1 in situ, thereby increasing the potential for systemic inflammation and leading to CNS KP dysregulation. Here, IDO1 is linked to depressive symptom measurement.